injection site itching tirzepatide Injection Site Itching with Tirzepatide:

Individual metabolism and biology Age, body weight, baseline metabolic rate, and even gut health all affect how you respond

Fatigue doesnt

Wegovy and Zepbound are registered trademarks of their respective manufacturers.

Obesity is no longer regarded as simply a failure of willpower but now a chronic illness with a biological cause (Couzin-Frankel Dec 2023)

Tirzepatide is a dual GLP-1 and GIP receptor agonist, meaning it targets two critical hormonal pathways involved in appetite control, insulin sensitivity, and fat metabolism

One phase IIb clinical trial administered setmelanotide to obese participants with heterozygous MC4R deficiency and obese controls over 28 days, observing a placebo-adjusted weight loss of 2.6 kg and 4.0 kg respectively [98]